CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 158 filers reported holding CLOVIS ONCOLOGY INC in Q4 2021. The put-call ratio across all filers is 1.47 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $659 | -95.6% | 12,500 | 0.0% | 0.00% | -100.0% |
| Q3 2022 | $15,000 | -37.5% | 12,500 | -5.0% | 0.01% | -40.0% |
| Q2 2022 | $24,000 | +84.6% | 13,153 | +97.7% | 0.02% | +150.0% |
| Q1 2022 | $13,000 | -27.8% | 6,653 | 0.0% | 0.01% | -33.3% |
| Q4 2021 | $18,000 | -40.0% | 6,653 | 0.0% | 0.01% | -52.6% |
| Q3 2021 | $30,000 | +66.7% | 6,653 | +111.0% | 0.02% | +72.7% |
| Q2 2021 | $18,000 | -18.2% | 3,153 | 0.0% | 0.01% | -31.2% |
| Q1 2021 | $22,000 | +214.3% | 3,153 | +110.2% | 0.02% | +166.7% |
| Q4 2020 | $7,000 | -22.2% | 1,500 | 0.0% | 0.01% | -33.3% |
| Q3 2020 | $9,000 | – | 1,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Coppell Advisory Solutions LLC | 229 | $11,008 | 0.00% |